SureTrader SureTrader SureTrader
Home > Boards > US OTC > Medical - Healthcare >

BioCorRx (BICX)

Add BICX Price Alert      Hide Sticky   Hide Intro
Moderator: Pip611
Search This Board:
Last Post: 1/19/2017 9:50:11 PM - Followers: 96 - Board type: Free - Posts Today: 0



About BioCorRx

Program Overview

BioCorRx (OTCBB: BICX) is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a treatment program that is used by various licensed alcohol addiction clinics throughout the United States.

The program consists of two components:BioCorRx has the worldwide rights (except in Australia and New Zealand) to a highly effective, proprietary implant formulation of the FDA-approved drug, naltrexone. After being surgically implanted by a medical professional, the naltrexone implant significantly reduces cravings for alcohol for as long as a year in some patients, depending on individual metabolism rates.BioCorRx also owns a life coaching program that is tailored specifically to alcoholics. Once a patient has received the implant, they are encouraged to enter the life coaching program to maximize results.

BioCorRx’s revolutionary alcohol treatment program has an 85% success rate as reported by patients in routine telephone and face to face interviews. The implant is administered as an outpatient procedure, and in most cases, patients do not need to miss more than one day of work. They are then able to enter the private life coaching program without co-workers or family members knowing, unless they so choose.


Naltrexone is a medication that blocks the effects of drugs known as opioids and was approved by the FDA in 1995 for the treatment of alcohol dependence.

Learn more about the side effects of naltrexone.

Naltrexone blocks the parts of the brain that "feel pleasure” when patients use alcohol. When these areas of the brain are blocked, patients feel significantly less cravings for alcohol and even if alcohol is used, the effects of it will be extremely limited - making sobriety the only option. Once medical intervention has reduced the physical need for alcohol, the program goes on to address the patient's psychological needs. The combination of these treatments has resulted in the highest chance of sobriety.

naltrexone implant

While other companies use naltrexone in their treatments, the drug is typically administered in oral or injection form, requiring their patients to be responsible for taking the medication or scheduling an appointment.

While some patients do well with the oral formulation, there is a drawback that it must be taken daily and a patient whose craving becomes overwhelming can obtain the euphoria simply by skipping a dose before resuming abuse. Patients who received the program developed by BioCorRx are treated with a slow release dose that can last up to year in many patients (depending on various factors such as metabolism rates), which gives the patients a higher success rate for the treatment of alcoholism.

The outpatient naltrexone implant procedure can take as little as 20 minutes under local anesthetic in some cases. Most patients can return to work or their daily routine in the same day, without the cravings for alcohol.

Mission, Vision, Values


BioCorRx is focused on providing leadership and innovation for the treatment of alcoholism by offering a high-quality, comprehensive and cost-effective recovery program that allows patients and their loved ones to celebrate freedom from the cycle of alcohol addiction. Our program is built on a strong foundation of experience and practice, allowing for an improved quality of life for recovering alcoholics.


BioCorRx strives to be the preeminent, long-term alcohol recovery program used by treatment centers around the world for alcoholics, as well as their family and friends. By providing patients a "Fresh Start" on life, they have the opportunity to live happier, healthier, more productive lives away from the damaging impact of alcohol. We have built an organization that is committed to nurturing research for cutting-edge alcohol recovery technologies and integrating those technologies with comprehensive alcohol recovery treatment programs.


BioCorRx provides the opportunity and tools to treatment centers so they can help patients live happier, healthier, and more productive lives to those suffering from alcohol addiction (as well as their family and friends) by helping them break the addiction cycle and live alcohol-free. We want patients to celebrate freedom from the past and hope for the future. Our team consists of physicians, coaches, founders and management that are committed to providing high-quality services and adherence to ethical care.

Our goal is to give our treatment center partners the ability to deliver our program in a timely, warm and compassionate way to give patients, as well as their families and friends, peace of mind. To achieve this, BioCorRx has built its program around highly-qualified alcohol addiction specialists and effective treatment solutions.

We are committed to quality and continuous improvement in order to meet our partners’ needs for an individualized program dedicated to alcohol addiction recovery.

Investors Overview

BioCorRx is uniquely poised to gain significant market share of the $22 billion annual alcohol treatment market in the US.

More than 7% of the US population ages 18 years and older or 13.8 million Americans have problems with drinking, including 8.1 million people who suffer from alcoholism. And the costs financially are staggering. Alcohol dependency and abuse costs the US over $220 billion a year. For the sake of comparison, this is greater than the amount of money spent to combat cancer ($196 billion) and obesity ($133 billion).

BioCorRx intends to distribute the program to a new clinic in the United States every 60 to 90 days. Clinics using our program are also holding discussions with major health insurance providers to pay for all or a portion of the treatment fees.

Business Model

BioCorRx’s research has discovered that demand for its services are high and that growth in highly marketed segments of the population may be achieved through partnering with additional clinic sites. The company is also exploring the sub-licensing of the program to select regions of the US and internationally.

BioCorRx's goal is to meet its growth targets through licensing opportunities by promoting its naltrexone implant product and counseling service model to existing medical clinics and treatment centers that will purchase the program and/or product from the company. In addition, Fresh Start Private intends to open corporately owned clinics in select key markets where it is deemed appropriate.

Stock Price & Charts

BioCorRx is a fully reporting company. Financial reports and other reports are available for view or by visiting the online website. Audited financial reports are available quarterly.

Company Structure Details

Watch Jeremy Miller on Fox News!

<iframe width="560" height="315" src="; frameborder="0" allowfullscreen></iframe>

<iframe width="560" height="315" src="" frameborder="0" allowfullscreen></iframe>


BICX Chart

Key Executives

Kent Emry - CEO, Director
Brady Granier -COO, Director
Lourdes Felix -CFO, Director
Dr. Jorge Andrade, Jr. - Director
Neil Muller -Co-Founder and President, Director 

Locations of independently owned clinics using our Fresh Start Program

Start Fresh Recovery
720 N. Tustin Ave.
Suite 206
Santa Ana, CA 92705

Start Fresh Executive Recovery
367 E Virginia Ave
Phoenix, AZ 85004
855-393-HOPE (4673) 

Fresh Start Private Florida
1415 Panther Lane
Suites 313-320
Naples, FL 34109

Start Fresh Alcohol Recovery Center
2827 S. 88th St
Omaha NE 68124

Coming Soon!

• San Francisco, California
• Chandler, Arizona
• North Scottsdale, Arizona
• Connecticut

Insider Interview Links

December 2, 2013 - Interview with Brady Granier COO
November 14, 2013 - SmallCapVoice Interview with Kent Emry CEO
October 2, 2013 - SmallCapVoice Interview with Brady Granier COO



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#7544  Sticky Note VIVITROL is injectable naltrexone produced by Alkermes plc Pip611 09/09/16 05:15:47 PM
#7651   I agree. I think we may finally Fido 01/19/17 09:50:11 PM
#7650   Little nibbles on the offer. Wouldn't take much Pip611 01/19/17 06:17:59 PM
#7649   Thank you for sharing. Fido 01/18/17 07:00:17 PM
#7648   Awsome news! I hope your son is Pip611 01/18/17 01:49:56 PM
#7647   Encouraging!! JB51 01/18/17 09:50:57 AM
#7646   Just though I would share this with everyone, captainhook002 01/18/17 09:45:51 AM
#7645   A good way to start spending the $5 Fido 01/13/17 08:54:40 AM
#7644   News !!! DREAM BIG 01/12/17 08:45:08 AM
#7643   Biocorrx is developing an improved version of injectable Pip611 01/06/17 04:49:07 PM
#7642   There is a severe opioid addiction issue in Fido 01/06/17 04:29:43 PM
#7641   Thanks for the insight. big orange 01/06/17 04:13:48 PM
#7640   Correct, insurance paying the fees has and continues Fido 01/06/17 03:32:30 PM
#7639   It will not be competitive in price. drugmanrx 01/06/17 03:29:31 PM
#7638   Hopefully someone on this board can answer this. big orange 01/06/17 03:12:45 PM
#7637   Ok new year, lets have some positive news!! JB51 01/05/17 08:58:06 PM
#7636   Amen! JB51 12/30/16 10:03:50 PM
#7635   Another year in the books with good ol' Trifecta78 12/30/16 05:38:48 PM
#7634   While a nice presentation, we here on this Fido 12/21/16 11:40:27 AM
#7633 DREAM BIG 12/21/16 11:02:10 AM
#7632   Am I sensing / seeing an upward trend DREAM BIG 12/21/16 09:37:23 AM
#7631   Would be ok if they don't sell out JB51 12/19/16 06:49:45 PM
#7630   Yeah !!! That would be big step if DREAM BIG 12/19/16 06:45:43 PM
#7629   Did anyone pick on what Brady (CEO) said Pip611 12/19/16 06:13:49 PM
#7628   Yes I also picked up another 50,000 shares JB51 12/14/16 03:08:15 PM
#7627   I will pick up some more in time. Fido 12/14/16 02:33:06 PM
#7626   Awesome short term goals within the next 3 Pip611 12/14/16 02:15:51 PM
#7625   Nice goals; fast track FDA approval, up-list (yeah, Fido 12/14/16 01:35:37 PM
#7624 DREAM BIG 12/14/16 01:03:15 PM
#7623   We should be truly hoping that the new Fido 12/13/16 07:12:42 PM
#7622   I haven't heard anything, but we had some Pip611 12/08/16 06:14:25 PM
#7621   Any news out of the presentation in LA?? JB51 12/08/16 04:13:20 PM
#7620   You know something, we don't!! JB51 12/07/16 02:16:08 PM
#7619   Anyone looking to add shares now is the time! Pip611 12/07/16 01:58:07 PM
#7618   Need many many more of these stories to JB51 11/29/16 04:53:07 PM
#7617 DREAM BIG 11/29/16 10:45:07 AM
#7616   Hopefully everything works out for the good, been JB51 11/28/16 01:54:19 PM
#7615   One thought to ponder is, how long will Fido 11/28/16 01:30:34 PM
#7614   Imo! Will FDA approval approaching , getting insurance DREAM BIG 11/28/16 01:26:21 PM
#7613   insurance always pays for FDA approved products. Pip611 11/28/16 01:23:33 PM
#7612   I added in the .03', .04 and .05's Pip611 11/28/16 01:13:38 PM
#7611   Very true, something I've stated a gazillion times Fido 11/28/16 01:11:42 PM
#7610   Remember we still need insurance to pay for it JB51 11/28/16 01:07:01 PM
#7609   What we know from this is that after Fido 11/28/16 01:04:02 PM
#7608   Agree, but we already have, IMO, a superior Fido 11/28/16 01:02:20 PM
#7607   Guys ! I am seriously thinking about adding DREAM BIG 11/28/16 12:35:15 PM
#7606   Fido ! If that FDA thing went through DREAM BIG 11/28/16 12:23:54 PM
#7605   Yippee, seems to be forward progress. Nice Fido 11/28/16 11:20:26 AM
#7604   Nice, looks like some favorable news, hopefully starts JB51 11/28/16 10:51:09 AM
#7603   NEWS !!!!! FDA Approval Process on its way DREAM BIG 11/28/16 09:23:45 AM
#7602   Hmmmm, thought we were finally on the right track. Fido 11/22/16 03:53:21 PM